{"name":"Angiex, Inc.","slug":"angiex-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AGX101","genericName":"AGX101","slug":"agx101","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AGX101","genericName":"AGX101","slug":"agx101","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNTVpkUkNuSVRQNVg0bElDNGpNMGxRdWtBNm5FaXhyazFjSW8tZ1ZZMDl3M01pcjd1ajJhVnpVOE1PY2txaHRfNHdHNnlQMW9zQWJBc3hnQzVSdEVta0JNUWxIamlhX0w4aVpCaEJxc01mdXZfckdSTVdKMXg5SnhQOTd2dURqUU5RRkl1Wktn?oc=5","date":"2025-11-17","type":"trial","source":"Yahoo Finance","summary":"Angiex Completes Financings Totaling $31 Million to Advance Phase 1 Dose Escalation of Nuclear-Delivered ADC AGX101 in Patients with Advanced Solid Tumors - Yahoo Finance","headline":"Angiex Completes Financings Totaling $31 Million to Advance Phase 1 Dose Escalation of Nuclear-Delivered ADC AGX101 in P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxONkNsUmo0MVlfUWlJdDFEX25jcWtPX1A3d3A2NldJM2lpMTFfa2tydW9FWlBMM3dHSHgxcXc2UU5KQ25FVHdRdF92bXlPSWdSWUJuWW9aTlNFUGpjendBZVphM0ZlUmxQV1lEaFNrYjNjR3JjS2psNGRaUnlMOTV0Rzl6cFVpV2xRMHpCUzhRWkFvOEFNYVJhY0FaT0ZoMHA4cVdRS1ptN2RLWldXV1loSVlEbnFDY3lMdlhidkxaM2JqN2FjUWlyMW14X3o4S19hMUNmcHAyR3pqRVd2SEtSdTBHMjlyUWx1N1dGVGt5TTBQdw?oc=5","date":"2022-06-22","type":"pipeline","source":"PR Newswire","summary":"Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer - PR Newswire","headline":"Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxONFUyWENNN0R2SjJYZHhtT0laZHAxQldzcmFCcm9lUWdFTmtwN2VtYzFWeGlaWVFYMURIRGJULU12SVpUR2tBY1pVbGxuaThWQ2dMQzJjQ0pJc0NremNtNFhwdjNCU3lNcmxsRW83dzNiUEJqNWVoZDh2YVhnZ2NmQ0xxalp6U3ozdXdqc1l4VHZoRlFmMTdaejJoYl9NUzg?oc=5","date":"2018-07-25","type":"pipeline","source":"Bloomberg.com","summary":"The Next Cancer Drug Might Start in Outer Space - Bloomberg.com","headline":"The Next Cancer Drug Might Start in Outer Space","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}